Oxbow Advisors LLC Boosts Stock Holdings in Colgate-Palmolive Company $CL

Oxbow Advisors LLC raised its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 4.6% during the second quarter, HoldingsChannel reports. The firm owned 31,719 shares of the company’s stock after purchasing an additional 1,391 shares during the period. Oxbow Advisors LLC’s holdings in Colgate-Palmolive were worth $2,883,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the business. Praxis Investment Management Inc. increased its position in Colgate-Palmolive by 24.6% during the 2nd quarter. Praxis Investment Management Inc. now owns 29,817 shares of the company’s stock valued at $2,710,000 after purchasing an additional 5,880 shares during the period. Aware Super Pty Ltd as trustee of Aware Super grew its position in shares of Colgate-Palmolive by 251.5% in the 2nd quarter. Aware Super Pty Ltd as trustee of Aware Super now owns 129,433 shares of the company’s stock worth $11,765,000 after buying an additional 92,613 shares during the last quarter. Evernest Financial Advisors LLC grew its position in shares of Colgate-Palmolive by 24.5% in the 2nd quarter. Evernest Financial Advisors LLC now owns 3,696 shares of the company’s stock worth $336,000 after buying an additional 727 shares during the last quarter. Turtle Creek Wealth Advisors LLC purchased a new position in shares of Colgate-Palmolive in the 2nd quarter worth approximately $337,000. Finally, Rosenberg Matthew Hamilton grew its position in shares of Colgate-Palmolive by 79.8% in the 2nd quarter. Rosenberg Matthew Hamilton now owns 3,110 shares of the company’s stock worth $283,000 after buying an additional 1,380 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $78.13 on Friday. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a 12 month low of $76.68 and a 12 month high of $101.89. The company has a 50 day simple moving average of $82.07 and a two-hundred day simple moving average of $87.49. The stock has a market cap of $63.15 billion, a price-to-earnings ratio of 21.95, a PEG ratio of 4.55 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business had revenue of $5.11 billion during the quarter, compared to analysts’ expectations of $5.03 billion. During the same period in the previous year, the business posted $0.91 EPS. The business’s quarterly revenue was up 1.0% compared to the same quarter last year. As a group, analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.7%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s payout ratio is presently 58.43%.

Wall Street Analyst Weigh In

CL has been the topic of a number of analyst reports. UBS Group cut their price objective on shares of Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Wednesday, October 8th. Citigroup cut their price objective on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a research report on Monday, August 4th. Deutsche Bank Aktiengesellschaft set a $86.00 price objective on shares of Colgate-Palmolive in a research report on Friday, October 10th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Colgate-Palmolive from $95.00 to $88.00 and set an “overweight” rating on the stock in a research report on Friday, October 10th. Eight research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $92.21.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.